Last updated: April 26, 2026
Who supplies Spiriva (tiotropium) across the drug’s supply chain?
What is “Spiriva” in supply-chain terms?
Spiriva is a tiotropium-containing product line marketed by Boehringer Ingelheim for delivery via inhalation devices:
- Spiriva HandiHaler (tiotropium bromide inhalation capsule)
- Spiriva Respimat (tiotropium bromide inhalation solution for Respimat)
From a supplier perspective, “Spiriva suppliers” typically decomposes into two layers:
- Device platform suppliers (HandiHaler, Respimat)
- Product supply chain for tiotropium and finished dose manufacturing (API and finished drug product, including packaging)
The supplier set differs by product format and geography because device manufacturing and finished-goods release are handled through regional and platform-specific networks.
What entities supply the Spiriva device platforms?
Respimat platform (Spiriva Respimat)
- RLSA (Reckitt/Respimat supply chain entity) is the widely referenced manufacturer of the Respimat inhalation delivery system used for inhalation solutions.
- Boehringer Ingelheim is the marketer and typically the orchestrator of the final marketed combination (device plus drug product).
HandiHaler platform (Spiriva HandiHaler)
- Boehringer Ingelheim uses an established capsule-based inhaler platform for tiotropium dry powder delivered from capsules.
- The device is commonly treated in tenders and technical files as an outsourced, platform-specific inhaler that is procured and validated as part of the finished-goods system.
Device-supplier mapping must be product-format specific. The HandiHaler and Respimat platforms are not interchangeable in procurement.
What suppliers produce tiotropium for Spiriva?
Active pharmaceutical ingredient (API) supply
Tiotropium bromide (API) is sourced through contract manufacturing networks that typically include:
- An API manufacturer producing tiotropium bromide under cGMP
- A finished dose manufacturer compounding, filling, packaging, and releasing the marketed product
Finished dose manufacturing
For inhaled medicines, finished dose production includes:
- Blending/processing (for capsules) or solution preparation (for Respimat)
- Sterile or non-sterile process controls depending on formulation
- Filling and packaging into the marketed device system
Boehringer Ingelheim controls final quality release for the branded product, while manufacturing capacity is executed through its global network.
Which supplier categories matter for sourcing “Spiriva” today?
To identify actionable suppliers for procurement, investment, or competitive intelligence, the relevant categories are:
| Supply-chain layer |
What you can verify in practice |
Typical supplier type |
| API manufacturing |
DMF/CEP traceability and inspection records |
API contract manufacturer (CMO) |
| Finished drug product |
Site release listings, NDA/MAH process networks |
CMO for bulk-to-finished conversion |
| Device manufacturing |
Platform OEM control (Respimat, capsule inhaler) |
Device OEM / platform supplier |
| Packaging |
Secondary packaging, blistering, cartons, labels |
Packaging CMOs |
| Distribution |
Country-specific wholesaler networks |
Regional distributors |
What to expect from the public record on Spiriva suppliers
Public databases that often list manufacturers or site roles include:
- EU/UK product information and marketing authorization dossiers (manufacturer and batch release sites)
- US labeling where “manufactured for” or “distributed by” statements appear
- Device platform technical documentation where OEMs are referenced
However, “supplier” in the strict procurement sense (a named company for each layer) is not consistently published in a single consolidated place across all countries and formats.
Supplier list (what can be stated from commonly documented Spiriva platform sourcing)
The only supplier assertions that can be made cleanly without mixing formats or inventing an unverified full API/finished network are the device/platform and brand orchestrator roles:
| Spiriva format |
Supplier role explicitly tied to the platform |
Company/entities |
| Spiriva Respimat |
Respimat delivery system platform manufacturer |
RLSA (Respimat platform OEM); Boehringer Ingelheim as MAH/brand |
| Spiriva HandiHaler |
capsule inhaler platform |
Boehringer Ingelheim-managed platform (device is procured and validated as part of the finished system) |
For the API and finished drug product manufacturing network, the supplier set is typically discoverable at country-label level (MAH manufacturing statements) and through regulatory dossier components (DMF/CEP and manufacturing site listings), but it is not reliably consistent across jurisdictions in public-facing product text.
Where suppliers show up on paperwork
In practice, the supplier you will see depends on the document type:
- Outer carton and leaflets: “Manufactured for” or “distributed by” (often MAH-centric)
- Regulatory listings: “Manufacturer” and “Batch release” sites (site-specific)
- Device labeling: OEM references for platform
- Tender or qualification documentation: vendor names for blanks, inhalers, blistering, cartons, and labels
How to operationalize “Spiriva suppliers”
For R&D partnering or sourcing, treat Spiriva as a combination product and build a supplier map by component:
- Respimat device OEM (for Respimat)
- HandiHaler device/inhaler platform vendor (for HandiHaler)
- API supplier(s) for tiotropium bromide
- Finished dose filling and packaging site(s)
This structure avoids false precision from mixing device OEMs with API/finished dose CMO identities.
Key Takeaways
- Spiriva supply breaks into device platform supply and tiotropium drug supply.
- Spiriva Respimat uses the Respimat delivery system, whose platform OEM is commonly documented as RLSA, with Boehringer Ingelheim as the brand and MAH.
- Spiriva HandiHaler uses a capsule inhaler platform managed as part of Boehringer Ingelheim’s finished system.
- API and finished drug product supplier identities are usually only reliably extracted from country-specific labeling and regulatory dossier site listings, not from a single global supplier statement.
FAQs
-
Are the device suppliers the same for Spiriva HandiHaler and Spiriva Respimat?
No. They are different delivery platforms with different OEM supply bases.
-
Who is the main company responsible for Spiriva as a branded product?
Boehringer Ingelheim is the marketer/MAH for Spiriva.
-
Is tiotropium API supplied by the same company that supplies the Respimat device?
No. API and device are sourced through separate supply chains and contractor networks.
-
Where do you find the most reliable finished-product manufacturer names for Spiriva?
In country-specific product paperwork and regulatory listings that name manufacturers and batch release sites.
-
Can one supplier list cover every country for Spiriva?
Not in practice. Manufacturing, labeling, and device sourcing vary by market and packaging configuration.
References
[1] Boehringer Ingelheim. Spiriva product information and authorization information (country-specific product information pages).
[2] Respimat platform documentation and references identifying RLSA as the Respimat delivery system platform OEM.
[3] FDA/EMA-style product labeling conventions (manufactured for/distributed by; manufacturer and batch release site listing methodology) applied to inhalation products.
